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Activation of the inflammatory cysteine protease caspase-1 in inflammasome complexes plays 
a critical role in the host response to microbial infections. Inflammasome activation induces 
inflammation through secretion of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18 
and through extracellular release of the alarmin high mobility group box 1. Moreover, caspase-1 
activation by inflammasomes counters bacterial replication and induces pyroptosis, a specialized 
cell death program that removes infected immune cells as part of the host defense system. 
It is thus not surprising that bacterial and viral pathogens evolved virulence factors targeting 
inflammasome activation and activity. Here, we provide an overview of the distinct inflammasome 
complexes that are activated in a pathogen-specific manner and discuss the diverse strategies 
employed by viruses and bacteria to modulate inflammasome function.
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inactivate glycolysis enzymes (Shao et al., 2007), and to induce 
a specialized form of cell death known as “pyroptosis” in macro-
phages infected with the bacterial pathogens Shigella flexneri, S. 
typhimurium, Pseudomonas aeruginosa, Legionella pneumophila, 
Bacillus  anthracis, Staphylococcus aureus, Listeria monocytogenes, 
and Francisella tularensis (Lamkanfi and Dixit, 2010). In addition to 
preventing pathogen replication in infected immune cells, pyropto-
sis may enhance host defense responses by presenting intracellular 
microbial antigens to cells of the immune system (Lamkanfi and 
Dixit, 2010; Miao et al., 2010).
Caspase-1 aCtivation by inflammasomes
Caspase-1 is produced as an inactive zymogen that is recruited and 
activated by cytosolic multi-protein complexes known as inflam-
masomes (Lamkanfi and Dixit, 2009). These protein complexes 
are assembled in cells of myeloid and epithelial origin upon rec-
ognition of DAMPs and pathogen-associated molecular patterns 
in intracellular compartments, similar to the role of mammalian 
Toll-like receptors at the cell surface and within endosomes (Kawai 
and Akira, 2006). Inflammasomes contain members of the NOD-
like receptor (NLR) or the HIN-200 receptor family, namely the 
NLRs Nlp1b, Nlrp3, and Nlrc4, or the HIN-200 protein absent in 
melanoma (AIM2; Figure 1). These receptors are recruited into 
the inflammasome in a pathogen-specific manner (Lamkanfi and 
Dixit, 2009). Nlrp3 is required for caspase-1 activation in response 
to microbial products with diverse molecular structures such 
as LPS, peptidoglycan, and lipoteichoic acid, upon exposure to 
microbial toxins and ionophores such as nigericin, endogenous 
alarmins such as ATP, and in response to infection with bacterial 
and fungal pathogens such as S. aureus, Streptococcus pneumoniae, 
and Candida albicans, respectively (Kanneganti et al., 2006a,b; 
Caspase-1: an inflammatory Cysteine protease
Caspases are evolutionary conserved cysteine proteases that cleave 
their substrates behind aspartate residues (Lamkanfi et al., 2002). 
Caspase-mediated substrate proteolysis results in activation or 
inactivation of critical signaling cascades regulating programmed 
cell death, differentiation, and cell proliferation (Lamkanfi et al., 
2006). Dysregulated activity of the founding father of mammalian 
caspases, interleukin (IL)-1β-converting enzyme and later renamed 
caspase-1, has been linked to inflammatory bowel diseases (Villani 
et al., 2009; Allen et al., 2010; Dupaul-Chicoine et al., 2010; Zaki 
et al., 2010a,b), gouty arthritis (Martinon et al., 2006), type II dia-
betes (Larsen et al., 2007), and less common autoinflammatory 
disorders that are collectively referred to as cryopyrinopathies 
(Lamkanfi and Kanneganti, 2010).
Caspase-1 modulates inflammatory and host defense responses 
against microbial pathogens by processing the precursor forms of 
the pro-inflammatory cytokines IL-1β and IL-18 into their bio-
logically active forms (Kuida et al., 1995; Li et al., 1995; Ghayur 
et al., 1997; Gu et al., 1997). Caspase-1-mediated maturation of 
IL-1β and IL-18 is critical for their secretion from activated mono-
cytes and macrophages. These related cytokines mediate critical 
aspects of the local and systemic immune response to infection 
including the induction of fever, transmigration of leukocytes into 
sites of injury or infection, and activation and polarization of T 
helper 1 (T
H
1) and T
H
2 responses (Dinarello, 2009). In addition 
to secreting IL-1β and IL-18, caspase-1 also mediates the release of 
the damage-associated molecular pattern (DAMP) high mobility 
group box 1 (HMGB1) from macrophages infected with the fac-
ultative intracellular pathogen Salmonella typhimurium (Lamkanfi 
et al., 2010). Moreover, caspase-1 was shown to activate the execu-
tioner caspase-7 (Lamkanfi et al., 2008; Akhter et al., 2009), to 
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activation of caspase-1 in macrophages infected with F. tularensis, 
L. monocytogenes and in response to DNA viruses such as cytome-
galovirus and vaccinia virus (Fernandes-Alnemri et al., 2010; Jones 
et al., 2010; Rathinam et al., 2010; Sauer et al., 2010).
Caspase-1 inhibition by orthopoxvirus-enCoded 
serpins
Given the central role inflammasomes play in modulating repli-
cation and dissemination of microbial pathogens, certain viruses 
and bacteria have evolved mechanisms to counter the induction 
of caspase-1 activation and activity. One mechanism by which 
microbial pathogens interfere with inflammasome functions is by 
directly targeting the enzymatic activity of caspase-1. The cow-
pox virus protein Cytokine response modifier A (CrmA) and its 
homologs in orthopoxviruses such as vaccinia, ectromelia, and 
rabbitpox virus probably represent the best characterized exam-
ples of this class of inflammasome inhibitors (Dobbelstein and 
Shenk, 1996; Macen et al., 1996; Turner et al., 2000; Best, 2008). 
Mariathasan et al., 2006; Sutterwala et al., 2006; McNeela et al., 
2010). In addition, the DAMPs monosodium urate and calcium 
pyrophosphate dehydrate crystals also activate the Nlrp3 inflam-
masome, suggesting a role for this inflammasome in the etiology of 
gouty arthritis and pseudogout (Martinon et al., 2006). By contrast, 
the Nlrc4 inflammasome is activated in macrophages infected with 
intracellular pathogens such as S. typhimurium, L. pneumophila, 
P. aeruginosa, and S. flexneri as illustrated by the observation that 
caspase-1 activation is largely abolished in Ipaf deficient macro-
phages infected with these intracellular pathogens (Mariathasan 
et al., 2004; Amer et al., 2006; Franchi et al., 2006, 2007; Miao et al., 
2006, 2008; Lamkanfi et al., 2007a; Sutterwala et al., 2007; Suzuki 
et al., 2007). In contrast, B. anthracis Lethal Toxin (LT) triggers 
activation of the Nlrp1b inflammasome in mouse macrophages and 
mutations in the Nlrp1b gene were identified as the key susceptibil-
ity locus for Anthrax LT-induced macrophage death (Boyden and 
Dietrich, 2006). Finally, additional inflammasome complexes such 
as the recently identified AIM2 inflammasome, are responsible for 
Figure 1 | Modulation of inflammasomes by microbial pathogens. 
Bacillus anthracis activates the Nlrp1b inflammasome, whereas 
Staphylococcus aureus, Streptococcus pneumonia, and Candida albicans 
induce caspase-1 activation via Nlrp3. Salmonella typhimurium, Shigella 
flexneri, Legionella pneumophila, and Pseudomonas aeruginosa all make use of 
a bacterial type III or IV secretion system to inject effector proteins that are 
recognized by the Nlrc4 inflammasome. Finally, Francisella tularensis induces 
activation of the AIM2 inflammasome when genomic DNA of replicating 
bacteria is detected in the cytosol of infected macrophages. Orthopoxviruses 
interfere with inflammasome function at several steps. They produce pyrin-only 
decoy proteins (vPOPs) that bind the inflammasome adaptor ASC to prevent 
caspase-1 recruitment and inhibit caspase-1 activity directly with virally 
encoded serpins such as the cowpox serpin CrmA and its homologs encoded 
by myxoma and vaccinia virus. Finally, orthopoxviruses evolved scavenger 
receptors for secreted IL-1β (vIL-1βR) and IL-18 (vIL-18BP) to prevent activation 
of downstream signaling cascades. Influenza virus NS1 protein dampens 
caspase-1 activation and secretion of IL-1β and IL-18 through a yet unknown 
mechanism that requires its amino-terminal RNA-binding domain. The Yersinia 
virulence factors YopE and YopT and the Pseudomonas effector ExoS inhibit 
caspase-1 activation, possibly through an indirect mechanism involving 
inhibition of Rho GTPase-mediated cytoskeletal changes. On the other hand, 
the phospholipase A2 activity of Pseudomonas ExoU is required for inhibiting 
caspase-1 activation, while Yersinia YopK prevents recognition of the bacterial 
type III secretion system.
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Fibroma virus S013L pyrin-only proteins (POPs) resemble the 
POPs and caspase recruitment domain (CARD)-only proteins 
encoded in the human genome (Lamkanfi et al., 2007b; Stehlik 
and Dorfleutner, 2007). The human CARD-only proteins COP, 
INCA, ICEBERG, and CASP12
S
 all bind the caspase-1 CARD to 
prevent activation of caspase-1 and the subsequent generation of 
IL-1β (Druilhe et al., 2001; Lee et al., 2001; Lamkanfi et al., 2004a,b; 
Saleh et al., 2006). In contrast, human cPOP1 and cPOP2, and 
viral POPs interact with the pyrin domain of the inflammasome 
adaptor protein ASC and pyrin motifs found in certain NLRs to 
prevent recruitment and activation of caspase-1 by inflammasomes 
(Stehlik and Dorfleutner, 2007). The relevance of vPOPs during 
infection is provided by the observation that deletion of the gene 
encoding myxoma virus M013L results in decreased viremia as a 
result of increased inflammatory responses and attenuated viral 
replication during myxomatosis (Johnston et al., 2005). Thus, the 
diverse mechanisms orthopoxviruses evolved to prevent and inter-
fere with caspase-1 signaling suggest that inflammasomes play a 
critical role in the host response against these pathogens.
inhibition of inflammasome signaling by influenza 
virus
Viral modulation of inflammasome signaling is not limited to the 
orthopoxviruses described above. Interestingly, Influenza virus uses 
an unrelated mechanism to prevent caspase-1 activation and inter-
fere with inflammasome signaling. Human influenza A/PR/8/34 
(H1N1) virus was shown to inhibit production of IL-1β and IL-18 
through inhibition of caspase-1 maturation in infected macro-
phages (Stasakova et al., 2005). Mutant viruses lacking the influenza 
NS1 gene were incapable of preventing caspase-1 activation and 
triggered secretion of significantly increased levels of IL-1β and 
IL-18 from infected host cells. These mutant viruses were attenu-
ated in vitro, but it is unclear whether caspase-1 activation is solely 
responsible for this phenotype. Regardless, structure– function 
studies demonstrated that the amino-terminal RNA-binding/
dimerization domain of NS1 is essential for inhibition of caspase-1 
activation and the secretion of mature IL-1β and IL-18, whereas 
the carboxy-terminal effector domain was not required (Stasakova 
et al., 2005). Although the molecular mechanism by which influenza 
NS1 inhibits caspase-1 activation has not been uncovered, NS1 may 
interfere with a critical step involved in inflammasome assembly. 
Further study in this direction may unveil interesting new mecha-
nisms by which viruses target inflammasomes.
negative regulation of inflammasome aCtivation by 
baCterial virulenCe faCtors
In addition to the viruses described above, several Gram-positive 
and –Gram-negative bacterial pathogens have been demonstrated to 
interfere with inflammasome activation. Enteropathogenic Yersinia 
enterocolitica bacteria employ a set of intriguing mechanisms to 
prevent caspase-1 activation and secretion of IL-1β and IL-18 
(Schotte et al., 2004). This Gram-negative pathogen makes use of 
a specialized type III secretion system to inject virulence factors 
called Yop proteins directly into the host cell cytosol. Among these 
effector proteins, YopE and YopT were shown to inhibit caspase-1 
activation and the subsequent secretion of mature IL-1β (Schotte 
et al., 2004). These Yop proteins are known to target Rho GTPases, 
Although classified as serine protease inhibitors (serpins), these 
virus-encoded proteins function as pseudosubstrate inhibitors of 
caspase-1 (Ray et al., 1992; Komiyama et al., 1994; Best, 2008). 
They form covalent bonds with the active site cysteine after being 
processed by caspase-1, thus blocking its enzymatic activity. Indeed, 
CrmA inhibits caspase-1 activity with a K
I
 of 0.01 nM, rendering 
it one of the most effective inhibitors known for this protease. 
Notably, CrmA shares 54% amino acid identity with the human 
serpin PI-9 (Sprecher et al., 1995) and has two homologs in rodents 
(Sun et al., 1997). Although the reactive loop aspartate residue 
where caspase-mediated processing occurs in CrmA is mutated to 
glutamate in PI-9 (Annand et al., 1999), the latter serpin is capa-
ble of inhibiting caspases as illustrated by the observation that 
it prevents caspase-1-mediated processing of IL-1β and IL-18 in 
vascular smooth muscle cells (Young et al., 2000). Importantly, in 
addition to blocking caspase-1 activation, CrmA and its homologs 
inhibit the protease activity of the apoptotic initiators caspases-8 
and -10 as well (Dobbelstein and Shenk, 1996; Macen et al., 1996; 
Turner et al., 2000; Best, 2008). Thus, poxviruses have devised a 
way to simultaneously interfere with inflammatory and apoptotic 
signaling cascades. Serpin-mediated caspase-1 inhibition prevents 
secretion of IL-1β and IL-18 and delays the induction of effective 
host defense responses. Moreover, by preventing programmed cell 
death of infected host cells, poxviruses can replicate in intracellular 
niches and spread to adjacent cells before being recognized by cells 
of the host’s immune system.
The critical role of CrmA and other serpins in poxvirus virulence 
is demonstrated by the observation that CrmA deficiency reduced 
the lesion size and numbers on the chorio-allantoic membrane of 
developing chick embryos (Ray et al., 1992; Palumbo et al., 1994). 
Moreover, deletion of CrmA attenuated virulence in intranasally 
and intracranially infected Balb/c and C57BL/6 mice (Thompson 
et al., 1993; Palumbo et al., 1994; MacNeill et al., 2009). Similarly, 
deletion of the CrmA homolog Serp2 in myxoma virus causes a 
dramatic reduction in viral titers in infected rabbits (Messud-Petit 
et al., 1998). By contrast, vaccinia virus mutants lacking the CrmA 
homologs SPI-1 and SPI-2 did not display changes in virulence in 
intranasally infected Balb/c mice (Kettle et al., 1995). This may be 
explained by the observation that vaccinia virus encodes a scav-
enger receptor called virus-encoded IL-1β receptor (vIL-1βR) that 
neutralizes secreted IL-1β (Kettle et al., 1997). In addition, vaccinia, 
ectromelia, and cowpox viruses encode soluble IL-18-binding pro-
teins (vIL-18BPs) that prevent activation of inflammatory path-
ways downstream of the IL-18 receptor (Smith et al., 2000). Thus, 
orthopoxviruses make use of serpins to inhibit caspase-1 activity 
and modulate signaling downstream of caspase-1 through scaven-
ger receptors to increase virulence.
inhibition of inflammasome assembly by 
orthopoxvirus deCoy proteins
In addition to modulating inflammasome signaling at the level of 
caspase-1 and its substrates, orthopoxviruses devised mechanisms 
to prevent activation of this inflammatory protease altogether. 
Indeed, Myxoma virus and Shope Fibroma virus encode pyrin-
only decoy molecules that interfere with inflammasome assembly 
to inhibit caspase-1 activation (Johnston et al., 2005; Dorfleutner 
et al., 2007). In this regard, the myxoma virus M013L and Shope 
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tuberculosis expresses a putative Zn2+ metalloprotease named Zmp1 
that prevents inflammasome activation and IL-1β secretion (Master 
et al., 2008). Zmp1-mediated inhibition of caspase-1 activation 
was demonstrated to enhance bacterial survival in infected mac-
rophages and to increase bacterial burdens in the lungs of aerosol-
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ConClusions and perspeCtives
Caspase-1 activation by inflammasomes is a critical component 
of the host response to microbial pathogens. It induces secretion 
of HMGB1, IL-1β, and IL-18 and triggers pyroptosis of infected 
host cells in order to eliminate the infectious agent. It may thus be 
beneficial to microbial pathogens to prevent inflammasome assem-
bly, to inhibit caspase-1 activation and activity and to interfere 
with downstream signaling cascades using decoy receptors. Studies 
showed that orthopoxviruses, influenza H1N1 virus and a variety 
of bacterial pathogens all evolved unique mechanisms to hijack the 
inflammasome machinery. Future studies will undoubtedly shed 
light on new and intriguing mechanisms by which bacterial and 
viral pathogens aim to silence the inflammasome.
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which are critical for cytoskeletal reorganization and phagocytosis. 
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is as a cysteine protease that inactivates Rho GTPases by removing 
the C-terminal prenyl membrane anchor that attaches them to 
the plasma membrane. Experiments with dominant-negative pro-
teins and chemical inhibitors of the Rho GTPase Rac1 suggested a 
critical role for this Rho GTPase in inflammasome assembly and 
caspase-1 activation (Schotte et al., 2004). In addition to YopE and 
YopT, the Yersinia pseudotuberculosis effector protein YopK prevents 
recognition of the bacterial type III secretion system by the Nlrp3 
and Nlrc4 inflammasomes in order to promote bacterial survival 
in host macrophages (Brodsky et al., 2010). Together, these find-
ings suggest that Yersinia spp. may prevent caspase-1 activation by 
inflammasomes by interfering with Rho GTPases and by masking 
the type III secretion system. However, the precise molecular chain 
of events by which Yop effector proteins affect inflammasome acti-
vation requires further analysis. L. pneumophila, the causative agent 
of Legionnaire’s disease, uses a different strategy to inhibit caspase-1 
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transcription of the inflammasome adaptor ASC to interfere with 
caspase-1-mediated restriction of bacterial replication in human 
monocytes (Abdelaziz et al., 2010). P. aeruginosa isolates expressing 
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ple of Gram-negative pathogens interfering with inflammasome 
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driven secretion of IL-1β and IL-18 from infected macrophages 
(Sutterwala et al., 2007). ExoS is another Pseudomonas effector pro-
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